ReNerve and RMIT awarded $499k grant
Filed with ASX · · 3 pages · English
Summary by 6ix AI
ReNerve Limited has announced that it, in collaboration with RMIT, has been awarded a grant for a nerve regeneration project. The funding will support research using patients' blood to enhance nerve regeneration after prostate surgery. This project aims to develop a gel that could be integrated into nerve repair products to improve surgical outcomes. ReNerve plans to keep shareholders updated on the project's progress as it develops.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Renerve
- Notice of Annual General Meeting/Proxy Form
- ReNerve - Corporate Governance Statement
- ReNerve - Appendix 4G
- ReNerve - Full Year Results
- ReNerve - 2026 Annual Report
Later from Renerve
- Change of Director's Interest Notice - J Chick
- Change in substantial holding - J Chick
- ReNerve completes first cases in Hong Kong and Malaysia
- ReNerve AGM Presentation
- Results of Meeting
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve